Role of the Blood–Brain Barrier in Multiple Sclerosis

Cited by (385)

Items 101–200 of 385

  1. Endothelial-Derived Extracellular Vesicles Induce Cerebrovascular Dysfunction in Inflammation
    David Roig-Carles, Eduard Willms, Ruud D. Fontijn, S Pacheco, Imre Mäger, Helga E. de Vries, Mark C. Hirst, Basil Sharrack, David Kingsley Male, Cheryl A. Hawkes et al. · 2021 · Pharmaceutics
  2. Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases
    Zakaria Louadi, Maria L. Elkjaer, Melissa Klug, Chit Tong Lio, Amit M. Fenn, Zsolt Illés, Dario Bongiovanni, Jan Baumbach, Tim Kacprowski, Markus List et al. · 2021 · Genome biology
  3. TLR2 Ligand Pam3CSK4 Regulates MMP-2/9 Expression by MAPK/NF-κB Signaling Pathways in Primary Brain Microvascular Endothelial Cells
    Hongyan Zhu, Rongrong Dai, Youquan Zhou, Hao Fu, Qiang Meng · 2018 · Neurochemical Research
  4. Mercury in the retina and optic nerve following prenatal exposure to mercury vapor
    Roger Pamphlett, Stephen Kum Jew, Svetlana Cherepanoff · 2019 · PLoS ONE
  5. Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
    Mária Péter, Wanda Török, Anna Petrovics-Balog, László Vı́gh, László Vécsei, Gabor E. Balogh · 2020 · Scientific Reports
  6. Gintonin mitigates experimental autoimmune encephalomyelitis by stabilization of Nrf2 signaling via stimulation of lysophosphatidic acid receptors
    Jong Hee Choi, Jinhee Oh, Min Jung Lee, Seong‐Gyu Ko, Seung-Yeol Nah, Ik‐Hyun Cho · 2020 · Brain Behavior and Immunity
  7. Glutamate Efflux across the Blood–Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System
    Benjamin Fredrick Gruenbaum, Alexander Anatolievich Zlotnik, Amit Frenkel, Ilya A. Fleidervish, Matthew Boyko · 2022 · Metabolites
  8. Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis
    Carla Rodriguez-Mogeda, Sabela Rodríguez‐Lorenzo, Jiji V. D. Attia, Jack van Horssen, Maarten E. Witte, Helga E. de Vries · 2022 · Biomolecules
  9. Inflammation-induced TRPV4 channels exacerbate blood–brain barrier dysfunction in multiple sclerosis
    Cathrin Elly Hansen, Alwin Kamermans, Kevin Mol, Kristina Berve, Carla Rodriguez-Mogeda, Wing Ka Fung, Bert van het Hof, Ruud D. Fontijn, Susanne M. A. van der Pol, Laura Michalick et al. · 2024 · Journal of Neuroinflammation
  10. Blood–Brain Barrier ( BBB ) Dysfunction in CNS Diseases: Paying Attention to Pericytes
    Tianrui Yu, Zixuan Wang, Yanghang Chen, Yuanyuan Xiang, Maoxiong Wu, Manqing Zhang, Xiaoping Yin, Zhiying Chen · 2025 · CNS Neuroscience & Therapeutics
  11. The microglia-blood vessel interactions in the developing brain
    Yuki Hattori · 2022 · Neuroscience Research
  12. Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis
    Jie Huang, Song Hee Han, Qi Sun, Yipeng Zhao, Junchen Liu, Xiaolu Yuan, Wenqian Mao, Biwen Peng, Wanhong Liu, Jun Yin et al. · 2017 · Cell & Bioscience
  13. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption
    Z. Al-Ahmady · 2018 · Expert Opinion on Drug Delivery
  14. Endothelial dysfunction at the cellular level in three dimensions: severity, acuteness, and distribution
    Vincent F. M. Segers, Tijs Bringmans, Gilles W. De Keulenaer · 2023 · American Journal of Physiology-Heart and Circulatory Physiology
  15. In vivo assessment of the human cerebral microcirculation and its glycocalyx: A technical report
    Roel H. L. Haeren, Kim Rijkers, Olaf E. M. G. Schijns, Jim T. A. Dings, Govert Hoogland, Marc A. M. J. van Zandvoort, Hans Vink, Jacobus J. van Overbeeke · 2018 · Journal of Neuroscience Methods
  16. Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers
    Monokesh Kumer Sen, Mohammed S. M. Almuslehi, Peter John Shortland, David Anthony Mahns, Jens R. Coorssen · 2021 · International Journal of Molecular Sciences
  17. Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
    Дубченко Екатерина Александровна, Alexander Vladimirovich Ivanov, Н. Н. Спирина, Н. Ф. Смирнова, Mikhail Melnikov, Alexey Boyко, Evgeniy Gusev, Aslan Amirkhanovitch Kubatiev · 2020 · Brain Sciences
  18. Cholesterol level correlate with disability score in patients with relapsing-remitting form of multiple sclerosis
    Monika Ďurfinová, Leona Procházková, Darina Petrleničová, Zuzana Bystrická, Katarína Orešanská, Ľ. Kuračka, Branislav Líška · 2018 · Neuroscience Letters
  19. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review
    Alfredo Sanabria‐Castro, Alberto Alape‐Girón, Marietta Flores-Dı́az, Ann Echeverri-McCandless, Alexander Parajeles · 2024 · Reviews in the Neurosciences
  20. Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
    Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova · 2024 · Journal of Neurology
  21. Understanding the Blood-Brain Barrier: From Physiology to Pathology
    Angela Garcia-Gallardo, Matthew Campbell · 2025 · Advances in experimental medicine and biology
  22. Blood Brain Barrier Permeability Could Be a Biomarker to Predict Severity of Neuromyelitis Optica Spectrum Disorders: A Retrospective Analysis
    Ying Wang, Mingqin Zhu, Caiyun Liu, Jinming Han, Wenjuan Lang, Yang Gao, Chao Lu, Shuang Wang, Shuai Hou, Nannan Zheng et al. · 2018 · Frontiers in Neurology
  23. The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
    Dafni Birmpili, Imane Charmarke Askar, Kévin Bigaut, Dominique Bagnard · 2022 · International Journal of Molecular Sciences
  24. Beyond wrecking a wall: revisiting the concept of blood–brain barrier breakdown in ischemic stroke
    Julia Castillo-González, Elena González‐Rey · 2024 · Neural Regeneration Research
  25. Impact of Physical Activity on Cellular Metabolism Across Both Neurodegenerative and General Neurological Conditions: A Narrative Review
    Vicente Javier Clemente‐Suárez, Alejandro Rubio-Zarapuz, Pedro Belinchón-deMiguel, Ana Isabel Beltrán-Velasco, Alexandra Martín-Rodríguez, José Francisco Tornero-Aguilera · 2024 · Cells
  26. The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid
    Barbara Anna Kutryb-Zając, Ada Kawecka, Fionä Caratis, Krzysztof Urbanowicz, Alicja Braczko, Tomomi Furihata, Bartosz Karaszewski, Ryszard Tomasz Smolenski, Aleksandra Rutkowska · 2022 · Frontiers in Molecular Neuroscience
  27. Hyperhomocysteinemia and Disease—Is 10 μmol/L a Suitable New Threshold Limit?
    Giada Marroncini, Serena Martinelli, Sara Menchetti, Francesco Bombardiere, Francesco Saverio Martelli · 2024 · International Journal of Molecular Sciences
  28. Glial Cells as Emerging Therapeutic Targets in Neurodegenerative Diseases: Mechanistic Insights and Translational Perspectives
    Thirupathirao Vishnumukkala, Che Mohd Nasril Che Mohd Nassir, Zaw Myo Hein, Prarthana Kalerammana Gopalakrishna, Barani Karikalan, Aisyah Alkatiri, Saravanan Jagadeesan, Venkatesh R Naik, Warren Thomas, Mohamad Aris Mohd Moklas et al. · 2025 · Cells
  29. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence
    Mahshid Yeganeh Salehpour, Adriano Mollica, Saeideh Momtaz, Nima Sanadgol, Mohammad Hosein Farzaei · 2019 · Clinical Drug Investigation
  30. Elevated Aortic Pulse Wave Velocity Relates to Longitudinal Gray and White Matter Changes
    Corey W. Bown, Omair A. Khan, Elizabeth E. Moore, Dandan Liu, Kimberly R. Pechman, Francis E. Cambronero, James G. Terry, Sangeeta Nair, L. Taylor Davis, Katherine A. Gifford et al. · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  31. The Effects of Curcumin on Astrocytes in Common Neurodegenerative Conditions
    Ameer A. Alameri, Muhammad Usman Ghanni, Arsalan Ali, Mandeep Singh, Moaed Emran Al-Gazally, Abbas Firras Almulla, Andrés Alexis Ramírez‐Coronel, Yasser Fakri Mustafa, Reena Gupta, Rasha Fadhel Obaid et al. · 2023 · Mini-Reviews in Medicinal Chemistry
  32. Isolation of Mouse Cerebral Microvasculature for Molecular and Single-Cell Analysis
    Hallel C. Paraiso, Xueqian Wang, Ping‐Chang Kuo, Destin Furnas, Barbara A. Scofield, Fen‐Lei Chang, Jui-Hung Jimmy Yen, I-Chen Ivorine Yu · 2020 · Frontiers in Cellular Neuroscience
  33. Dapsone, More than an Effective Neuro and Cytoprotective Drug
    Araceli Díaz-Ruiz, Juan A. Nader, Francisco Calderón‐Estrella, Alfonso Mata-Bermúdez, Laura Álvarez-Mejía, Camilo Ríos · 2021 · Current Neuropharmacology
  34. Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis
    Ahmed Nadeem, Sheikh F. Ahmad, Naif Obaid Al-Harbi, Wedad S. Sarawi, Sabry Mohamed Attia, Wael A. Alanazi, Khalid E. Ibrahim, Sary Alsanea, Saleh Abdullah Alqarni, Ali S. Alfardan et al. · 2022 · International Immunopharmacology
  35. Potentially toxic elements in the brains of people with multiple sclerosis
    Roger Pamphlett, Michael E. Buckland, David Bishop · 2023 · Scientific Reports
  36. Human Endogenous Retroviruses in Neurodegenerative Diseases
    Gabrielle L. Adler, Kelvin Le, YuHong Fu, Woojin Scott Kim · 2024 · Genes
  37. Central nervous system vascularization in human embryos and neural organoids
    Sarah Boutom, Teresa Pereira Silva, Sean P. Palecek, Eric V. Shusta, Tiago G. Fernandes, Randolph Scott Ashton · 2024 · Cell Reports
  38. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis
    Hammad Ullah, О. В. Товчига, Maria Daglia, Haroon Zaman Khan · 2021 · Current Neuropharmacology
  39. White matter disease derived from vascular and demyelinating origins
    Linjie Zhang, De‐Cai Tian, Li Yang, Kaibin Shi, Yaou Liu, Yilong Wang, Fu‐Dong Shi · 2023 · Stroke and Vascular Neurology
  40. Blood brain barrier inflammation and potential therapeutic role of phytochemicals
    Welcome, Menizibeya O. · 2020 · PharmaNutrition
  41. Mesenchymal stromal/stem cells from perinatal sources: biological facts, molecular biomarkers, and therapeutic promises
    Mohammed Zohair Allouh, Syed Faizan Ali Rizvi, Ali Alamri, Yusuf Jimoh, Salma Aouda, Zakaria H. Ouda, Mohammad I. K. Hamad, Mick J. Perez-Cruet, G. Rasul Chaudhry · 2025 · Stem Cell Research & Therapy
  42. Inhibition of lysophosphatidic acid receptor 1–3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress
    Jong Hee Choi, Jinhee Oh, Min Jung Lee, Hyunsu Bae, Seong‐Gyu Ko, Seung-Yeol Nah, Ik‐Hyun Cho · 2021 · Journal of Neuroinflammation
  43. Structural retinal changes in cerebral small vessel disease
    S. Magdalena Langner, Jan Henrik Terheyden, Clara F. Geerling, Christine Kindler, Vera C. Keil, Christopher A. Turski, Gabrielle N. Turski, Charlotte Behning, Maximilian W. M. Wintergerst, Gabor C. Petzold et al. · 2022 · Scientific Reports
  44. Neuroprotective effects of bornyl acetate on experimental autoimmune encephalomyelitis via anti-inflammatory effects and maintaining blood-brain-barrier integrity
    Joon-Il Lee, Jonghee Choi, Tae-Woo Kwon, Hyo-Sung Jo, Do-Geun Kim, Seong‐Gyu Ko, Gyun Jee Song, Ik‐Hyun Cho · 2022 · Phytomedicine
  45. Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination
    Nathaly Espitia Pinzón, Berta Sanz‐Morello, John J. P. Brevé, John G. J. M. Bol, Benjamin Drukarch, Jan Bauer, Wia Baron, Anne‐Marie van Dam · 2017 · Scientific Reports
  46. Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care
    Ofira Einstein, Abram Katz, Tamir Ben‐Hur · 2022 · Autoimmunity Reviews
  47. An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond
    Ruba S. Saadeh, Paola A. Ramos, Alicia Algeciras‐Schimnich, Eoin P. Flanagan, Sean Joseph Pittock, Maria Alice V. Willrich · 2022 · Clinical Chemistry
  48. New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?
    Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Angelica Varesi, Martina Morozzi, Linda Mascione, Giovanni Ricevuti, Ciro Esposito, Nicoletta Galeotti, Alessia Pascale · 2024 · Pharmacological Research
  49. Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?
    Aude Metzger, Emmanuelle Le Bars, Jérémy Deverdun, François Molino, Bénédicte Maréchal, Marie‐Christine Picot, Xavier Ayrignac, Clarisse Carra Dalliere, Luc Bauchet, Alexandre Krainik et al. · 2017 · European Radiology
  50. Serum amyloid A-induced blood-brain barrier dysfunction associated with decreased claudin-5 expression in rat brain endothelial cells and its inhibition by high-density lipoprotein in vitro
    Matsumoto, Junichi, Dohgu, Shinya, Takata, Fuyuko, Iwao, Takuro, Kimura, Ikuya, Tomohiro, Misaki, Aono, Kentaro, Kataoka, Yasufumi, Yamauchi, Atsushi · 2020 · Neuroscience Letters
  51. Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE
    Filippos Stavropoulos, Elena Georgiou, Irene Sargiannidou, Kleopas A. Kleopa · 2021 · Pharmaceuticals
  52. Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights
    Jonathan Pansieri, Gina Hadley, Andrew Lockhart, Marco Pisa, Gabriele C. DeLuca · 2023 · Frontiers in Neurology
  53. Clinical significance of soluble adhesion molecules in anti‐ NMDAR encephalitis patients
    Yuewen Ding, Cheng-Jia Yang, Zheyi Zhou, Peng Yu, Jinyu Chen, Suyue Pan, Hong Mei Xu, Yuping A. Cai, Kaiyun Ou, Wei Xie et al. · 2019 · Annals of Clinical and Translational Neurology
  54. The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein–Barr virus infection, and vitamin D
    Tayebeh Latifi, Arghavan Zebardast, Sayed Mahdi Marashi · 2021 · Multiple Sclerosis and Related Disorders
  55. Plasma levels of soluble NCAM in multiple sclerosis
    Nicole Ziliotto, Robert Zivadinov, Dejan Jakimovski, Marcello Baroni, Veronica Tisato, Paola Secchiero, Niels Bergsland, Deepa Preeti Ramasamy, Bianca Weinstock‐Guttman, Francesco Bernardi et al. · 2018 · Journal of the Neurological Sciences
  56. Tension at the gate: sensing mechanical forces at the blood–brain barrier in health and disease
    Cathrin Elly Hansen, David Hollaus, Alwin Kamermans, Helga E. de Vries · 2024 · Journal of Neuroinflammation
  57. Review on theranostic and neuroprotective applications of nanotechnology in multiple sclerosis
    Anshul Sharma, Nitin Sharma, Sachin Kumar Singh, Kamal Dua · 2023 · Journal of Drug Delivery Science and Technology
  58. Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
    Aleksandra V. Petrovskaya, Artem M. Tverskoi, Angela Medvedeva, Maria A. Nazarova · 2023 · Communications Biology
  59. Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses
    Seiichi Omura, Eiichiro Kawai, Fumitaka Sato, Nicholas E. Martinez, Alireza Minagar, Mahmoud Al‐Kofahi, J. Winny Yun, Urška Cvek, Marjan Trutschl, Jonathan Steven Alexander et al. · 2018 · Frontiers in Immunology
  60. Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: Implication in traumatic and inflammatory brain injuries
    Seungho Choi, Nishant Saxena, Tajinder S. Dhammu, Mushfiquddin Khan, Avtar Kaur Singh, Inderjit Singh, Je‐Seong Won · 2018 · Nitric Oxide
  61. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders
    Javeria Fatima, Yasir Hasan Siddique · 2024 · CNS & Neurological Disorders - Drug Targets
  62. Interaction Between Neutrophils and Elements of the Blood–Brain Barrier in the Context of Multiple Sclerosis and Ischemic Stroke
    Anna Nowaczewska-Kuchta, Dominika Justyna Ksiazek-Winiarek, Andrzej R Glabinski · 2025 · International Journal of Molecular Sciences
  63. Spatiotemporal resolution of spinal meningeal and parenchymal inflammation during experimental autoimmune encephalomyelitis
    Bandana Shrestha, Xi Jiang, Shujun Ge, Debayon Paul, Peter E. Chianchiano, Joel S. Pachter · 2017 · Neurobiology of Disease
  64. Connexins in oligodendrocytes and astrocytes: Possible factors for demyelination in multiple sclerosis
    Cong‐Yuan Xia, Jie‐Kun Xu, Chenhao Pan, Wenwen Lian, Yan Yu, Bing-Zhi Ma, Jun He, Wei‐Ku Zhang · 2020 · Neurochemistry International
  65. The blood-brain barrier in health, neurological diseases, and COVID-19
    Jianan Chen, Rongbang Tan, Yuqian Mo, Jingjing Zhang · 2022 · Fundamental Research
  66. Emerging point‐of‐care autologous cellular therapy using adipose‐derived stromal vascular fraction for neurodegenerative diseases
    Rawan Al‐kharboosh, Jonathan Perera, Alexandra R. Bechtle, Guojun Bu, Alfredo Quiñones‐Hinojosa · 2022 · Clinical and Translational Medicine
  67. Identification of Key Ferroptosis-Related Genes in the Peripheral Blood of Patients with Relapsing-Remitting Multiple Sclerosis and Its Diagnostic Value
    Xi Song, Zixuan Wang, Zixin Tian, Meihuan Wu, Yitao Zhou, Jun Zhang · 2023 · International Journal of Molecular Sciences
  68. The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis
    Sujan Kumar Sarkar, Annie M. L. Willson, Margaret A. Jordan · 2024 · Journal of Immunology Research
  69. NADPH Oxidase 3: Beyond the Inner Ear
    Marc Herb · 2024 · Antioxidants
  70. Decreased Astrocytic CCL2 Accounts for BAF-312 Effect on PBMCs Transendothelial Migration Through a Blood Brain Barrier in Vitro Model
    Simona Federica Spampinato, Sara Merlo, Giuseppe Costantino, Yasuteru Sano, Takashi Kanda, Maria Angela Sortino · 2021 · Journal of Neuroimmune Pharmacology
  71. Microneedles: A Versatile Drug Delivery Carrier for Phytobioactive Compounds as a Therapeutic Modulator for Targeting Mitochondrial Dysfunction in the Management of Neurodegenerative Diseases
    Akshay Bandiwadekar, Kartik Bhairu Khot, Gopika Gopan, Jobin Jose · 2022 · Current Neuropharmacology
  72. Blood Vessels as a Key Mediator for Ethanol Toxicity: Implication for Neuronal Damage
    Kei Nakayama, Hiroshi Hasegawa · 2022 · Life
  73. Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells
    Julia Mamana, Gabrielle M. Humber, Eric R. Espinal, Soojung Seo, Nadine Vollmuth, Jon Sin, Brandon J. Kim · 2023 · Frontiers in Cellular and Infection Microbiology
  74. Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells
    Nathaly Espitia Pinzón, Hanneke van Mierlo, Jenny C. de Jonge, John J. P. Brevé, John G. J. M. Bol, Benjamin Drukarch, Anne‐Marie van Dam, Wia Baron · 2019 · Frontiers in Cellular Neuroscience
  75. The neurovascular unit in leukodystrophies: towards solving the puzzle
    Parand Zarekiani, Henrique Nogueira Pinto, Elly M. Hol, Marianna Bugiani, Helga E. de Vries · 2022 · Fluids and Barriers of the CNS
  76. Quantification of Blood-Brain-Barrier Permeability Dysregulation and Inflammatory Activity in MS Lesions by Dynamic-Contrast Enhanced MR Imaging
    M. Oghabian, A. Fatemidokht, Mohammad hosien Haririchian · 2022 · Basic and Clinical Neuroscience
  77. COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels
    William Danilo Fernandes de Souza, Denise Morais da Fonseca, Alexandrina Sartori · 2023 · Cells
  78. Emerging role of extracellular vesicles in multiple sclerosis: From cellular surrogates to pathogenic mediators and beyond
    Paola Loreto Palacio, Michelle L. Pleet, Eduardo Reátegui, Setty M. Magaña · 2023 · Journal of Neuroimmunology
  79. microRNAs: key modulators of disease-modifying therapies in multiple sclerosis
    Naeim Ehtesham, Meysam Mosallaei, Mohammad Reza Karimzadeh, Hossein Moradi Kazerouni, Mohammadreza Sharifi · 2020 · International Reviews of Immunology
  80. Distinct mechanisms underlying therapeutic potentials of CD20 in neurological and neuromuscular disease
    Tao-Xiang Chen, Yuanteng Fan, Biwen Peng · 2022 · Pharmacology & Therapeutics
  81. A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature
    Alicia M. Kemble, Benoit Hornsperger, Iris Ruf, Hans Georg Richter, Jörg Benz, Bernd Kuhn, Dominik Heer, Matthias Wittwer, Britta Engelhardt, Uwe Grether et al. · 2022 · PLoS ONE
  82. Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
    Siyao Li, Koki Sakurai, Masahiro Ohgidani, Takahiro A. Kato, Takatoshi Hikida · 2023 · Molecular Brain
  83. Conditioned medium-preconditioned EPCs enhanced the ability in oligovascular repair in cerebral ischemia neonatal rats
    Ning Zhou, Lei Wang, Ping Fu, Zihao Cui, Yuhang Ge, Feiyu Jiang, Jing Liu, Chao Ren, Zuo Luan, Hongbin Fan et al. · 2021 · Stem Cell Research & Therapy
  84. Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier
    Saba Hammad, Aloïse M Mabondzo, Rifat Hamoudi, Rania Harati · 2021 · Journal of Pharmaceutical Sciences
  85. Vascular multiple sclerosis: addressing the pathogenesis, genetics, pro-angiogenic factors, and vascular abnormalities, along with the role of vascular intervention
    Priyadarshi Prajjwal, Anagha Shree, Soumyajit Das, Pugazhendi Inban, Shankhaneel Ghosh, Arihant Senthil, Jaiprakash Gurav, Mrinmoy Kundu, Mohammed Dheyaa Marsool Marsool, Srikanth Gadam et al. · 2023 · Annals of Medicine and Surgery
  86. Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis
    Simões-Abade, Madalena B. C., Patterer, Marlene, Nicaise, Alexandra M., Pluchino, Stefano · 2024 · Frontiers in Cellular Neuroscience
  87. First record on mercury accumulation in mice brain living in active volcanic environments: a cytochemical approach
    Alicia Navarro‐Sempere, Yolanda Segovia, Armindo Rodrigues, Patrícia Garcia, Ricardo Camarinho, Magdalena Garcı́a · 2020 · Environmental Geochemistry and Health
  88. Potential role of the gut microbiota in neuromyelitis optica spectrum disorder: Implication for intervention
    Chunping Cui, Yiwen Ruan, Wei Qiu · 2020 · Journal of Clinical Neuroscience
  89. Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity
    Dongren Sun, Rui Wang, Qin Du, Hongxi Chen, Ziyan Shi, Yangyang Zhang, Nana Zhang, Xiaofei Wang, Hongyu Zhou · 2024 · Journal of Affective Disorders
  90. Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord
    Daniel Gratch, David Do, Pouya Khankhanian, Matthew K. Schindler, J. Eric Schmitt, Joseph R. Berger · 2020 · Multiple Sclerosis and Related Disorders
  91. Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease
    Xi Liu, Ling Shen, Bing Han, Honghong Yao · 2021 · Non-coding RNA Research
  92. X-linked genetic risk factors that promote autoimmunity and dampen remyelination are associated with multiple sclerosis susceptibility
    Kirill Borziak, Joseph Finkelstein · 2022 · Multiple Sclerosis and Related Disorders
  93. Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients
    Christoph Daniel Friedli, Franca Wagner, Helly Noemi Hammer, Nicole Kamber, Roland Wiest, Lara Diem, Andrew Chan, Anke Salmen, Robert Hoepner · 2022 · Multiple Sclerosis Journal
  94. Thymoquinone improves experimental autoimmune encephalomyelitis by regulating both pro-inflammatory and anti-inflammatory cytokines
    Roya Kazemi, Esmaeil Yazdanpanah, Seyed‐Alireza Esmaeili, Bahman Yousefi, Rasoul Baharlou, Dariush Haghmorad · 2024 · Molecular Biology Reports
  95. Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics
    Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, Elizaveta J. James, Mainthan Palendira, Simon H Hawke, Georges E. Grau · 2024 · Sclerosis
  96. Polyphenols as Wnt/β‐catenin pathway modulators: A promising strategy in clinical neurodegeneration
    Biswajit Kumar Utpal, Sajib Chandra Roy, Mehrukh Zehravi, Sherouk Hussein Sweilam, A. Dinesh Raja, M. Akiful Haque, Chandan Nayak, Senthilkumar Balakrishnan, Laliteshwar Pratap Singh, Saswati Panigrahi et al. · 2025 · Animal Models and Experimental Medicine
  97. Hyperhomocysteinemia and endothelial dysfunction in patients with cerebral vascular and autoimmune diseases
    Дубченко Екатерина Александровна, Alexander Vladimirovich Ivanov, А. Н. Бойко, Н. Н. Спирина, Evgeny I. Gusev, Aslan Amirkhanovich Kubatiev · 2019 · S S Korsakov Journal of Neurology and Psychiatry
  98. Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study
    Shih‐Han Susan Huang, Katerina Pavenski, Ting‐Yim Lee, Michael Todd Jurkiewicz, Aditya Bharatha, Jonathan Dale Thiessen, Keith St. Lawrence, Jean Théberge, Jennifer L. Mandzia, David S. Barth et al. · 2021 · Blood Advances
  99. COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case–control study
    Mohammad Rahmani, Abdorreza Naser Moghadasi, Shayan Shahi, Sharareh Eskandarieh, Hossein Azizi, Alireza Hasanzadeh, Ali Ahmadzade, Ali Zare Dehnavi, Ramin Hamidi Farahani, Mohammad Aminianfar et al. · 2022 · Medicina Clínica
  100. Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis
    Ali Amini Harandi, Fatemeh Siavoshi, Siavash Shirzadeh Barough, Asghar Amini Harandi, Hossein Pakdaman, Mohammad Ali Sahraian, Zahra Fathtabar, Faezeh Mohammadi, Faezeh Karamiani, Seyed Hossein Ardehali · 2022 · NeuroImmunoModulation